Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011299576> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2011299576 endingPage "195" @default.
- W2011299576 startingPage "187" @default.
- W2011299576 abstract "A total of 2484 target bacterial pathogens were collected (one per patient episode) from patients in 16 Latin American medical centers located in seven nations during 2011. Isolate identity was confirmed at a coordinating laboratory and susceptibility testing was performed for ceftaroline and comparator agents according to reference broth microdilution methods. A total of 30.0% of isolates were from respiratory tract, 29.4% from skin and skin structure, 21.4% from blood stream, 7.9% from urinary tract and 11.3% from other sites. Ceftaroline was active against Staphylococcus aureus (42.8% MRSA) with 83.6% of the isolates at ≤1 mg/L and all isolates at ≤2 mg/L (MIC5090, 0.25/2 mg/L). National MRSA rates ranged from a low of 28.8% in Colombia to a high of 68.1% in Chile. All Streptococcus pyogenes and Streptococcus agalactiae were susceptible to ceftaroline (MIC50/90 values were at ≤0.015/≤0.015 mg/L for both). All Streptococcus pneumoniae were susceptible to ceftaroline, linezolid, tigecycline and vancomycin. Susceptibility to ceftriaxone was at 88.4% (CLSI non-meningitis interpretive criteria) and 73.9% (CLSI meningitis interpretive criteria) for all S. pneumoniae. Ceftriaxone susceptibility was only at 33.3% (CLSI non-meningitis interpretive criteria) and 0.0% (CLSI meningitis interpretive criteria) for penicillin-intermediate (penicillin MIC, 4 mg/L) strains. All Haemophilus influenzae (29.4% β-lactamase-positive) isolates were susceptible to ceftaroline, amoxicillin–clavulanate, ceftriaxone, and levofloxacin. For the Latin American region, the ESBL-phenotype rate was 37.6% for Escherichia coli and 53.3% for Klebsiella pneumoniae. Ceftaroline was not active against ESBL-phenotype strains but was active against >90.0% of the non-ESBL-phenotype. The spectrum of activity of ceftaroline against pathogens from Latin America indicates that it merits further study for its potential use in the Latin American region." @default.
- W2011299576 created "2016-06-24" @default.
- W2011299576 creator A5006715126 @default.
- W2011299576 creator A5008542312 @default.
- W2011299576 creator A5026620873 @default.
- W2011299576 date "2014-03-01" @default.
- W2011299576 modified "2023-10-18" @default.
- W2011299576 title "Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)" @default.
- W2011299576 cites W2015652530 @default.
- W2011299576 cites W2024912832 @default.
- W2011299576 cites W2034794380 @default.
- W2011299576 cites W2035275497 @default.
- W2011299576 cites W2065590100 @default.
- W2011299576 cites W2081109135 @default.
- W2011299576 cites W2100926508 @default.
- W2011299576 cites W2101562941 @default.
- W2011299576 cites W2103158733 @default.
- W2011299576 cites W2126389238 @default.
- W2011299576 cites W2133912342 @default.
- W2011299576 cites W2134375266 @default.
- W2011299576 cites W2144012207 @default.
- W2011299576 cites W2149296540 @default.
- W2011299576 cites W2149940840 @default.
- W2011299576 cites W2155965882 @default.
- W2011299576 cites W4237533259 @default.
- W2011299576 doi "https://doi.org/10.1016/j.bjid.2013.11.005" @default.
- W2011299576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24513484" @default.
- W2011299576 hasPublicationYear "2014" @default.
- W2011299576 type Work @default.
- W2011299576 sameAs 2011299576 @default.
- W2011299576 citedByCount "18" @default.
- W2011299576 countsByYear W20112995762015 @default.
- W2011299576 countsByYear W20112995762016 @default.
- W2011299576 countsByYear W20112995762018 @default.
- W2011299576 countsByYear W20112995762019 @default.
- W2011299576 countsByYear W20112995762020 @default.
- W2011299576 countsByYear W20112995762021 @default.
- W2011299576 countsByYear W20112995762022 @default.
- W2011299576 countsByYear W20112995762023 @default.
- W2011299576 crossrefType "journal-article" @default.
- W2011299576 hasAuthorship W2011299576A5006715126 @default.
- W2011299576 hasAuthorship W2011299576A5008542312 @default.
- W2011299576 hasAuthorship W2011299576A5026620873 @default.
- W2011299576 hasBestOaLocation W20112995761 @default.
- W2011299576 hasConcept C174802600 @default.
- W2011299576 hasConcept C176947019 @default.
- W2011299576 hasConcept C2776520383 @default.
- W2011299576 hasConcept C2777027569 @default.
- W2011299576 hasConcept C2778980435 @default.
- W2011299576 hasConcept C2779489039 @default.
- W2011299576 hasConcept C2780950330 @default.
- W2011299576 hasConcept C2781253189 @default.
- W2011299576 hasConcept C2781276175 @default.
- W2011299576 hasConcept C2781414143 @default.
- W2011299576 hasConcept C501593827 @default.
- W2011299576 hasConcept C523546767 @default.
- W2011299576 hasConcept C54355233 @default.
- W2011299576 hasConcept C71924100 @default.
- W2011299576 hasConcept C86803240 @default.
- W2011299576 hasConcept C89423630 @default.
- W2011299576 hasConceptScore W2011299576C174802600 @default.
- W2011299576 hasConceptScore W2011299576C176947019 @default.
- W2011299576 hasConceptScore W2011299576C2776520383 @default.
- W2011299576 hasConceptScore W2011299576C2777027569 @default.
- W2011299576 hasConceptScore W2011299576C2778980435 @default.
- W2011299576 hasConceptScore W2011299576C2779489039 @default.
- W2011299576 hasConceptScore W2011299576C2780950330 @default.
- W2011299576 hasConceptScore W2011299576C2781253189 @default.
- W2011299576 hasConceptScore W2011299576C2781276175 @default.
- W2011299576 hasConceptScore W2011299576C2781414143 @default.
- W2011299576 hasConceptScore W2011299576C501593827 @default.
- W2011299576 hasConceptScore W2011299576C523546767 @default.
- W2011299576 hasConceptScore W2011299576C54355233 @default.
- W2011299576 hasConceptScore W2011299576C71924100 @default.
- W2011299576 hasConceptScore W2011299576C86803240 @default.
- W2011299576 hasConceptScore W2011299576C89423630 @default.
- W2011299576 hasIssue "2" @default.
- W2011299576 hasLocation W20112995761 @default.
- W2011299576 hasLocation W20112995762 @default.
- W2011299576 hasLocation W20112995763 @default.
- W2011299576 hasLocation W20112995764 @default.
- W2011299576 hasOpenAccess W2011299576 @default.
- W2011299576 hasPrimaryLocation W20112995761 @default.
- W2011299576 hasRelatedWork W1955488388 @default.
- W2011299576 hasRelatedWork W2018382434 @default.
- W2011299576 hasRelatedWork W2100856600 @default.
- W2011299576 hasRelatedWork W2104726155 @default.
- W2011299576 hasRelatedWork W2116203961 @default.
- W2011299576 hasRelatedWork W2121843771 @default.
- W2011299576 hasRelatedWork W2769336366 @default.
- W2011299576 hasRelatedWork W2980950197 @default.
- W2011299576 hasRelatedWork W3155113170 @default.
- W2011299576 hasRelatedWork W3195958508 @default.
- W2011299576 hasVolume "18" @default.
- W2011299576 isParatext "false" @default.
- W2011299576 isRetracted "false" @default.
- W2011299576 magId "2011299576" @default.
- W2011299576 workType "article" @default.